OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Enhancing these processes involves fine-tuning various variables, including cell line engineering, media composition, and bioreactor settings. A key goal is to amplify antibody production while reducing production costs